Variables | DFS | OS | ||
---|---|---|---|---|
∆LRχ2 | P-value | ∆LRχ2 | P-value | |
CP + PD-1 vs. CP | 4.83 | 0.0280* | 2.95 | 0.0856 |
CP + PD-L1 vs. CP | 5.22 | 0.0224* | 3.95 | 0.0469* |
CP + CD274 vs. CP | 3.66 | 0.0559 | 4.32 | 0.0378* |
CP + PDCD1 vs. CP | 4.12 | 0.0425* | 6.55 | 0.0105* |
CP + CD274 + PDCD1 vs. CP | 4.49 | 0.1057 | 6.12 | 0.0469* |
CP + PD-L1 + CD274 vs. CP | 4.11 | 0.1278 | 7.02 | 0.0299* |
CP + PD-1+ + PDCD1 vs. CP | 6.35 | 0.0417* | 9.53 | 0.0085* |
CP + CD8+PD-1+ vs. CP | 7.53 | 0.0061* | 3.16 | 0.0753 |
CP + IFNG vs. CP | 7.50 | 0.0062* | 5.29 | 0.0214* |
CP Clinicopathological parameters (patient age, tumor grade, tumor size and lymph node status), PD-1 + PD-1+ immune infiltrates (every 1 cell increment), PD-L1 PD-L1 tumor cell expression, LR Likelihood Ratio, CD8 + PD-1 + CD8+PD-1+ T cells
*Statistically significant